To further understand the association between CD86 expression and immunoassay sites in AML, the differences in chemokine, immunostimulator, MHC protein, and immune receptor expression were compared between the high vs. low CD86 expression groups (Supplementary Table 2). The gene discussed is CD86; the disease is acute myeloid leukemia.